Skip to content

Radial Immuno-Test for Human C-Reactive Protein

by Kent Laboratories, Inc.

510(k) K831958

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK831958 Date19 Jul 1983ClearedStatusActive

Official records

From the FDA record

Received by the FDA
17 Jun 1983
FDA decision
19 Jul 1983 (Substantially Equivalent)
FDA review time
32 days from receipt to decision

From the FDA 510(k) record K831958 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
Radial Immuno-Test for Human C-Reacti
510(k) Number
FDA product code
DCK
Device class
Class II
Regulation
21 CFR Part 866.5270
Advisory committee
Immunology
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is a C-Reactive Protein, Antigen, Antiserum, and Control as classified under FDA regulation 866.5270. It functions as an immunodiffusion assay designed to qualitatively detect human C-reactive protein (CRP) in serum or plasma, a marker used in clinical immunology for assessing inflammation or infection. The test relies on radial immunodiffusion principles, where antigen-antibody interactions form visible precipitation lines proportional to CRP concentration.

The Radial Immuno-Test for Human C-Reactive Protein is supplied as a kit for in vitro diagnostic use in clinical laboratories. It is intended for single-use and requires no special handling beyond standard laboratory procedures. The device received FDA 510(k) clearance (K831958) under the Traditional pathway, with a decision of Substantially Equivalent (SESE) in 1983. No MRI safety or sterility specifications are noted in the regulatory data, and the product is classified as a Class II device under FDA guidelines.

Similar devices

Other devices filed under FDA product code DCK (C-Reactive Protein, Antigen, Antiserum, And Control).

Other devices from Kent Laboratories, Inc.

See all devices from Kent Laboratories, Inc. →